Erythromycin Estolate Market, Global Outlook and Forecast 2023-2030
The global Erythromycin Estolate market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Erythromycin Estolate is an antibacterial agent and a macrolide antibiotic with a target spectrum similar to penicillin....
0 Σχόλια
0 Μοιράστηκε